What is UBS Tokenize?
Tokenization brings the benefits of digitalization and blockchain technology to regulated financial assets. It has the potential to reimagine capital markets for issuers and investors.
As blockchain technology has evolved, UBS has developed UBS Tokenize as a full-service offer for digital asset services, opening the door to the world of decentralized finance to a broader range of market participants and bringing them closer together.
UBS Tokenize supports opportunities across origination, distribution, and custody, initially focusing on tokenization of bonds, funds, and structured products.
Our 4 pillars

Innovative product framework
By taking regulated financial assets into the world of decentralized finance, we can provide tangible benefits across the full value chain. UBS Tokenize offers on-chain issuance capabilities, based on an innovative product framework and blockchain technology.

Blockchain and technology agnostic
Putting you in control and ensuring you are not dependent on a single technology framework. Being blockchain agnostic means UBS Tokenize’s open architecture seamlessly integrates to your existing systems and supports multiple Distributed Ledger Technology (DLT) networks.

Regulated products
As digital technologies potentially introduce new risks, ensuring regulatory compliance is key. The UBS Tokenize product framework enables you to customize the product that you bring into the decentralized world according to your compliance needs and requirements.

Institutional-grade offering
UBS’s deep-rooted position in financial markets means we’ve created a resilient and adaptable origination service to foster innovation. Equipped with best-in-class smart contract level governance, your products can access new audiences more efficiently while also benefiting from institutional-grade infrastructure and a wealth of expertise.
Your role within UBS Tokenize
Issuers
Issuers
Are you looking to expand the reach of your products and unlock opportunities for new audiences?
We offer:
Distributors
Distributors
Do you sell funds, structured products, and other solutions to end investors?
We offer:
Investors
Investors
Are you looking for new investment opportunities?
We offer:
Data providers
Data providers
Are you looking to extend the reach of your data sets to new audiences?
You can profit from:
Your toolkit for digital markets
UBS Tokenize puts you in control. Based on your digital strategy, you can utilize the full service or just parts of it.

From initial design through to documenting digital assets, our digital assets origination service provides expert guidance and a full-end-to-end service.

We offer:
- Extensive knowledge of the market to support the design, documentation, and tokenization of assets

Our tokenization services enable the issuance of a selection of assets on public and private blockchains.

We offer:
- Expert support to help initiate and issue assets on public and private blockchains
- Flexibility to construct product frameworks specific to your business and operational requirements, minimizing dependence on external suppliers

New distribution networks connect assets to an emerging and diverse investor audience.

You can benefit from:
- Connection with new investor bases, benefiting from the network effects for selected internal and external distribution
- Tokenization allows assets to be fractionalized into smaller tickets compared to traditional markets

UBS engages regulated custodians for the custody of UBS Tokenize assets.

You can benefit from:
- Integrated custody / IT infrastructure
- Selected third-party custodians when required
How digital technology is revolutionizing markets
We understand our clients’ needs are evolving – and digital technology is key to creating more opportunities. UBS Tokenize supports you at every step, helping you to stay ahead of the game.
Recent awards

Digital Asset Innovation Bank of the Year (Global)
Best Tokenized Real-World Asset Solution
Most impactful Tokenization use case
Latest news
Guardian Fixed Income Framework
Joint report developed by the Monetary Authority of Singapore’s Guardian Fixed Income Industry Group. The report was led by UBS AG, in collaboration with Global Financial Markets Association (GFMA) and International Capital Market Association (ICMA).
Our journey
UBS in partnership with our global client base, has long been at the cutting edge of applying the power of blockchain technology and digital assets.
FAQ
Get in touch
Disclaimer:
This material has been issued by UBS AG and/or any of its affiliates ("UBS" and "we", "us"). The securities, derivatives or other financial instruments described herein ("Instruments") may not be eligible for sale in all jurisdictions or to certain categories of investors. This material is for distribution only under such circumstances as may be permitted by applicable law, rules and/or regulations. All communications between you and us may be monitored. Please see further details as set out under "Country-specific information" below. Provenance and purpose This material has been prepared by sales or trading personnel and it is not a product of our Research Department and is not intended to recommend, suggest or inform an investment strategy. Opinions expressed may differ from the opinions expressed by our other divisions, including those of the Research Department. Recipient to exercise own judgment The information contained herein should not be regarded by recipients as a substitute for the exercise of their own judgment. It has no regard to the specific investment objectives, financial situation or particular needs of any specific recipient and does not constitute the provision of investment advice. Prior to entering into a transaction, you should consult with your own legal, regulatory, tax, financial and accounting advisers to the extent you deem necessary to make your own investment, hedging and trading decisions. Not an offer to transact This material has been prepared for informational purposes only and is not an offer to buy or sell or a solicitation of an offer to buy or sell any Instrument or to participate in any particular trading strategy. This material is not an official confirmation of terms. Conflicts of Interest This material may contain proprietary commentary produced in conjunction with our trading desks that trade as principal in the Instruments. This commentary may therefore not be independent from our proprietary interests or those of connected parties which may conflict with your interests. We may have accumulated or may acquire a long or short position in the subject Instrument, or derivative thereof, on the basis of this material prior to its dissemination. We may trade as principal or otherwise act or have acted as market-maker and/or as an execution venue in the Instruments. Instruments may be highly illiquid which may adversely impact the price, spread and speed of execution of orders in those Instruments. Furthermore, we may have or have had a relationship with or may provide or have provided investment banking, capital markets and/or other financial services to the companies associated with the Instruments. We have policies and procedures designed to manage conflicts of interest. In order to control the flow of information contained in one or more areas within UBS, into other areas, units, groups or affiliates of UBS, we may rely on information barriers. Additional information can be found at: ubs.com/ibterms. Contents of Material This material is prepared from information believed to be reliable, but we make no representations or warranties, express or implied, and owe no duties (including in negligence) as to the accuracy, completeness or reliability of the information contained herein, nor is it intended to be a complete statement or summary of the Instruments, markets or developments referred to in the materials. The information contained in this material is as of the date hereof only and is subject to change without notice. We do not undertake any obligation to update this material. Any prices or quotations contained herein are indicative only and are not for valuation purposes. Past performance is not necessarily indicative of future results. Statement of Risk The Instruments are not suitable for all investors, and trading in these Instruments is considered risky and is appropriate only for sophisticated investors and in particular any target market identified herein. These Instruments may involve a high degree of risk and may be highly volatile in response to fluctuations in interest rates, foreign exchange rates and other market conditions. Some Instruments may be physically settled, or cash settled. No Liability To the fullest extent permitted by law, neither we nor any of our directors, employees or agents is liable for any loss (including indirect, special or consequential losses or damages, and even if we have been advised of the possibility of loss) arising out of any person’s use of, or reliance upon, the information contained herein. Securities Act Any Instruments that have not been registered under the United States Securities Act of 1933 may not be offered or sold in the United States except pursuant to an exception from the registration requirements of the Securities Act and applicable state securities laws and in such circumstances as may be permitted by applicable law. No redistribution or reproduction We specifically prohibit the redistribution or reproduction of this material in whole or in part without our prior written permission and we accept no liability whatsoever for the actions of third parties in this respect. Scenario Analysis The scenario analyses shown in this material are based on model-based valuation methodologies and the results provided by them may vary significantly depending (i) on the data used as inputs; and (ii) on the assumptions and other parameters embedded in the model, which are not the only ones that might reasonably have been selected. They are based in part on information and market data which may be subject to change. We are not under any obligation to update the analyses. The scenario analyses are illustrative only and present hypothetical performance analyses of the Instrument based on certain assumptions with respect to specific factors that may prove to be incorrect. They are not intended to predict actual results for the Instrument and actual results may differ substantially from those provided or projected. We make no representation or warranty, express or implied, as to the accuracy or completeness or fitness for use for any particular purpose of the analysis or calculation methodology used. You should review and understand the assumptions and evaluate whether they are appropriate for your purposes.
Country-specific information
Except as otherwise specified herein, these materials are distributed to professional clients only, and are not suitable for retail clients. For further important country-specific information, please see the following link: www.ubs.com/sales-and-trading-country-information
© UBS 2025. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.



